|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
LH | Kirchgraber Paul R | CEO, Covance Drug Development | May 19 | Option Exercise | 182.51 | 4,300 | 784,793 | 17,246 | May 23 08:06 AM |
LH | Kirchgraber Paul R | CEO, Covance Drug Development | May 19 | Sale | 216.91 | 4,300 | 932,707 | 12,946 | May 23 08:06 AM |
LH | Kirchgraber Paul R | CEO, Covance Drug Development | Feb 21 | Option Exercise | 182.51 | 3,000 | 547,530 | 17,069 | Feb 23 09:54 AM |
LH | Kirchgraber Paul R | CEO, Covance Drug Development | Feb 21 | Sale | 250.58 | 8,000 | 2,004,675 | 9,069 | Feb 23 09:54 AM |
LH | Kirchgraber Paul R | CEO, Covance Drug Development | May 06 | Sale | 276.55 | 2,500 | 691,375 | 7,844 | May 10 08:21 AM |
LH | Kirchgraber Paul R | CEO, Covance Drug Development | Nov 04 | Sale | 214.14 | 1,500 | 321,204 | 7,698 | Nov 06 09:06 AM |
LH | Kirchgraber Paul R | CEO, Covance Drug Development | Apr 03 | Option Exercise | 0.00 | 1,010 | 0 | 8,459 | Apr 07 04:21 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite